Skip to main content
. 2021 Aug 3;12(12):2212–2220. doi: 10.1111/jdi.13606

Table 1.

Baseline characteristics of the diabetic ICU survivors and nonsurvivors

Survivors

(n = 310)

Nonsurvivors

(n = 192)

All patients (n = 502) P value
Sex (male), n (%) 184 (59.4) 101 (52.6) 285 (56.8) 0.140
Age (years) 79 (68, 85) 83 (77, 86.8) 81 (71.8, 85.3) <0.001*
BMI (kg/m2) 24.2 (21.7, 26.1) 23.9 (21.5, 26.1) 24.2 (21.6, 26.1) 0.245
APACHE II score 19 (14, 24) 25.4 ± 8.7 21 (15, 27) <0.001*
Surgical patients, n (%) 43 (13.9) 15 (7.8) 58 (11.6) 0.044*
Insulin therapy before ICU, n (%) 133 (42.9) 86 (44.8) 219 (43.6) 0.711
Reasons for ICU admission, n (%)
Sepsis 74 (23.9) 83 (43.2) 157 (31.3) <0.001*
Thoracic or respiratory disease 97 (31.3) 45 (23.4) 142 (28.3) 0.066
Cardiac and vascular disease 59 (19.0) 42 (21.9) 101 (20.1) 0.492
Neurologic disease 20 (6.5) 5 (2.6) 25 (6.5) 0.059
Renal dysfunction 19 (6.1) 8 (4.2) 27 (5.4) 0.418
Gastrointestinal disease 19 (6.1) 6 (3.1) 25 (5.0) 0.146
Postoperative care 14 (4.5) 2 (1.0) 16 (3.2) 0.036*
Other 8 (2.6) 1 (0.5) 9 (1.8) 0.163
Patient comorbidities
Respiratory disease 63 (20.3) 47 (24.5) 110 (21.9) 0.318
Cardiac and vascular disease 272 (87.7) 167 (95.3) 390 (90.6) 0.004*
Cerebrovascular disease 205 (66.1) 113 (58.9) 318 (63.3) 0.106
Chronic renal disease 113 (36.5) 91 (47.4) 178 (40.6) 0.019*
Gastrointestinal disease 20 (6.5) 16 (8.3) 36 (7.2) 0.478
Malignancy 64 (20.6) 31 (16.1) 95 (18.9) 0.241
*

P < 0.05. APACHE II scores, Acute Physiology and Chronic Health Evaluation II score.